Molina Healthcare (NYSE:MOH) Releases FY 2029 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2029 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 25.000-25.000 for the period, compared to the consensus estimate of 28.930. The company issued revenue guidance of -.

Molina Healthcare Stock Down 3.0%

Shares of MOH traded down $5.78 during midday trading on Friday, hitting $186.07. The company had a trading volume of 1,540,457 shares, compared to its average volume of 1,372,895. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $333.00. The company’s 50 day moving average price is $152.32 and its 200 day moving average price is $158.52. The stock has a market cap of $9.69 billion, a price-to-earnings ratio of 55.05 and a beta of 0.85.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the prior year, the firm earned $6.08 EPS. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts predict that Molina Healthcare will post 5.21 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on MOH shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $129.00 price objective on shares of Molina Healthcare in a research report on Friday, April 24th. Morgan Stanley boosted their price objective on shares of Molina Healthcare from $128.00 to $146.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. Mizuho decreased their target price on shares of Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research report on Thursday, March 12th. Finally, Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research report on Wednesday, April 29th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $169.60.

Institutional Trading of Molina Healthcare

A number of institutional investors have recently made changes to their positions in MOH. Baird Financial Group Inc. acquired a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $210,000. NewEdge Advisors LLC lifted its stake in shares of Molina Healthcare by 33.4% in the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after acquiring an additional 277 shares during the period. Jones Financial Companies Lllp lifted its stake in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after acquiring an additional 1,448 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Molina Healthcare by 19.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after acquiring an additional 40,531 shares during the period. Finally, Woodline Partners LP acquired a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $1,541,000. 98.50% of the stock is owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.